Lecture 3a - BS3420
Lipoproteins Defined: Macromolecular complexes that facilitate the transport of lipid-soluble compounds between various tissues in the body, ensuring that essential lipids reach their targets efficiently. These complexes are vital for the transport of:
Energy Metabolism Substrates: Provide fatty acids and triglycerides for energy production.
Essential Cellular Components: Supply phospholipids and cholesterol necessary for cell membrane structure and function.
Hormone Precursors: Carry lipid-derived hormones which are crucial for various physiological processes.
Eicosanoids: Transport signaling molecules that play significant roles in inflammation and cellular communication.
Lipid-soluble Vitamins: Ensure the delivery of vitamins like A, D, E, and K which are vital for numerous body functions.
Bile Acid Precursors: Provide cholesterol derivatives necessary for fat digestion and absorption in the intestine.
Importance of Lipoproteins:
Alterations in lipid metabolism can lead to severe chronic diseases, particularly atherosclerosis and coronary heart disease (CVD). These conditions are characterized by the accumulation of plaques in blood vessels, which can lead to cardiovascular complications. CVDs are recognized as the leading global cause of death, responsible for 30% of all deaths, with projections indicating a continuous rise in mortality from these diseases. Therefore, understanding lipoprotein function is paramount in developing strategies for prevention and treatment.
Cholesterol Biosynthesis and Its Regulation:
Key Nobel Prize winners in cholesterol biosynthesis include Konrad Bloch, Feodor Lynen, John Cornforth, George Popják, Michael Brown, and Joseph Goldstein. Their research has outlined the biosynthetic pathways and regulatory mechanisms involved in cholesterol production and its crucial role in cellular membranes and signaling.
Composition and Properties of Human Lipoproteins:
Components:
Lipoproteins are composed of apolipoproteins and lipids, including phospholipids, cholesterol, cholesteryl esters, and triacylglycerols.
HDL (High-Density Lipoprotein) has the highest protein content, contributing to its greater density among lipoproteins, and plays a crucial role in reverse cholesterol transport.
Visual Characteristics:
Chylomicrons: 50-200 nm diameter, least dense, and the largest lipoproteins, primarily responsible for dietary lipid transport.
VLDL (Very Low-Density Lipoprotein): 28-70 nm, responsible for transporting endogenous triglycerides from the liver to peripheral tissues.
LDL (Low-Density Lipoprotein): 20-25 nm, known as the “bad” cholesterol due to its association with plaque formation in arteries.
HDL: 8-11 nm, often referred to as “good” cholesterol for its role in reducing cardiovascular risk by transporting cholesterol back to the liver.
Functions of Apolipoproteins:
Major Components:
Apolipoproteins are classified from A-E, with Roman numeral suffixes indicating the order of separation from chromatography. Their functions include:
Interaction with receptors for cellular uptake, ensuring that lipids are delivered to the right tissues.
The amphipathic nature of these proteins allows them to function effectively in both lipid-rich (hydrophobic) and aqueous (hydrophilic) environments, which is essential for lipoprotein metabolism and transport.
Apolipoprotein Details:
Apolipoprotein | Molecular Weight | Lipoprotein Association | Function |
|---|---|---|---|
ApoA-I | 28,331 | HDL | Activates LCAT; interacts with ABC transporter for cholesterol efflux. |
ApoA-II | 17,380 | HDL | Modulates HDL metabolism. |
ApoIV | 44,000 | Chylomicrons, HDL | Implicated in postprandial lipid metabolism. |
ApoB-48 | 240,000 | Chylomicrons | Fundamental for chylomicron assembly and secretion. |
ApoB-100 | 513,000 | VLDL, LDL | Binds LDL receptor, essential for LDL clearance. |
ApoC-I | 7,000 | VLDL, HDL | Involved in lipid metabolism regulation. |
ApoC-II | 8,837 | Chylomicrons, VLDL, HDL | Activates lipoprotein lipase, crucial for triglyceride hydrolysis. |
ApoC-III | 8,751 | Chylomicrons, VLDL, HDL | Inhibits lipoprotein lipase, impacting triglyceride levels. |
ApoD | 32,500 | HDL | Function not fully characterized; potential role in inflammation. |
ApoE | 34,145 | Chylomicrons, VLDL, HDL | Triggers clearance of VLDL and chylomicron remnants from circulation. |
Lipoprotein Transport Mechanisms:
Exogenous Pathway:
Dietary lipids are packed into chylomicrons, with ApoCII activating lipoprotein lipase, which hydrolyzes triacylglycerols to fatty acids for tissue uptake. Chylomicron remnants are then absorbed by the liver via ApoE.
Endogenous Pathway:
Liver-derived lipids are transported to various tissues through VLDL. As lipids are extracted, LDL forms and is responsible for delivering cholesterol to extrahepatic tissues for biological functions.
Reverse Transport:
HDL is responsible for transporting excess cholesterol from peripheral tissues back to the liver for conversion to bile salts and excretion.
Receptor-Mediated Endocytosis:
Mechanism:
The binding of LDL to its receptor initiates endocytosis via clathrin-coated pits, leading to the internalization of the LDL particle. This particle is degraded in lysosomes, releasing free cholesterol for cellular utilization. After endocytosis, LDL receptors are recycled back to the membrane for subsequent binding. Backup receptors such as LRP (Low-Density Lipoprotein Receptor-Related Protein) were elucidated by Brown and Goldstein, contributing to the understanding of lipoprotein metabolism.
Atherosclerosis and Lipoprotein Dysfunction:
Pathophysiology:
Atherosclerosis is a slow, progressive disease characterized by lipid deposition in the walls of blood vessels, leading to inflammation and plaque formation, which can narrow or block arteries. Increased levels of LDL prompt monocyte differentiation into macrophages, leading to the formation of foam cells that contribute to plaque stability and growth.
LDL Modification:
LDL can be oxidized, altering ApoB's ability to bind its receptors, resulting in increased macrophage uptake of oxidized LDL, which is more atherogenic.
Familial Hypercholesterolemia (FH):
This genetic condition is caused by deficiencies in LDL receptors, leading to elevated plasma cholesterol levels and an accelerated progression of atherosclerosis. Mutations in the LDLR gene can disrupt normal cellular uptake of LDL, contributing to disease severity.
Risk Factors for Atherosclerosis:
Non-modifiable: Age, male gender, genetic predispositions.
Modifiable: Factors include hyperlipidemia, hypertension, smoking, diabetes, dietary habits, and infections. Intensifying awareness and managing these risk factors are essential in preventing atherosclerosis and its complications.
Summary of Lipoprotein Roles in Health:
Maintaining proper lipoprotein function, specifically LDL and HDL, is crucial for regulating cholesterol levels, cell membrane integrity, and preventing atherosclerosis. Dysregulation of these systems—including receptor deficiencies, oxidative modifications, and unhealthy lifestyle choices—can lead to severe health complications such as cardiovascular diseases, emphasizing the need for early interventions and lifestyle changes.